Protein Kinase C Inhibition With Ruboxistaurin Increases Contractility and Reduces Heart Size in a Swine Model of Heart Failure With Reduced Ejection Fraction.
JACC Basic Transl Sci
; 2(6): 669-683, 2017 Dec.
Article
en En
| MEDLINE
| ID: mdl-30062182
ADHF, acute decompensated heart failure; DIG, digitalis; DOB, dobutamine; ECG, electrocardiogram; EDPVR, end-diastolic pressure-volume relationship; EDV, end-diastolic volume; ESPVR, end-systolic pressure-volume relationship; ESV, end-systolic volume; Ees, elastance end-systole; HF, heart failure; HFrEF, heart failure with reduced ejection fraction; IR, ischemiareperfusion; LAD, left anterior descending coronary artery; LV, left ventricle/ventricular; LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; LVVPed10, left ventricular end-diastolic volume at a pressure of 10 mm Hg; LVVPes80, left ventricular end- systolic volume at a pressure of 80 mm Hg; MI, myocardial infarction; PKA, protein kinase A; PKC, protein kinase C; PKCα/ß inhibitor; PLN, phospholamban; PRSW, pre-load recruitable stroke work; RBX, ruboxistaurin; acute myocardial infarction; heart failure with reduced ejection fraction; invasive hemodynamics; positive inotropy
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
Idioma:
En
Revista:
JACC Basic Transl Sci
Año:
2017
Tipo del documento:
Article
Pais de publicación:
Estados Unidos